SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $90,802,681 | +33.9% | 90,815,000 | +31.6% | 5.68% | +164.7% |
| Q4 2022 | $67,802,325 | +1.3% | 69,010,000 | 0.0% | 2.14% | +32.9% |
| Q3 2022 | $66,940,000 | -0.1% | 69,010,000 | 0.0% | 1.61% | +4.9% |
| Q2 2022 | $66,983,000 | -1.0% | 69,010,000 | 0.0% | 1.54% | 0.0% |
| Q1 2022 | $67,673,000 | -0.5% | 69,010,000 | 0.0% | 1.54% | -13.6% |
| Q4 2021 | $68,018,000 | +0.3% | 69,010,000 | 0.0% | 1.78% | -9.7% |
| Q3 2021 | $67,802,000 | +17.5% | 69,010,000 | +17.5% | 1.97% | +9.2% |
| Q2 2021 | $57,717,000 | +1.7% | 58,708,000 | -0.3% | 1.81% | -20.2% |
| Q1 2021 | $56,759,000 | +1.7% | 58,877,000 | 0.0% | 2.26% | -35.2% |
| Q4 2020 | $55,835,000 | +46.9% | 58,877,000 | +42.7% | 3.50% | +1.7% |
| Q3 2020 | $38,009,000 | +44.8% | 41,266,000 | +38.3% | 3.44% | -4.5% |
| Q2 2020 | $26,252,000 | +156.4% | 29,830,000 | +134.0% | 3.60% | +87.2% |
| Q1 2020 | $10,237,000 | – | 12,749,000 | – | 1.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 37,347,000 | $36,345,000 | 4.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 51,663,000 | $49,804,000 | 2.44% |
| Wellesley Asset Management | 19,638 | $19,107,000 | 2.29% |
| Radcliffe Capital Management, L.P. | 58,877,000 | $56,759,000 | 2.26% |
| DeepCurrents Investment Group LLC | 29,151,000 | $28,254,000 | 0.97% |
| Penn Mutual Asset Management, LLC | 675,000 | $651,000 | 0.74% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,212,000 | $6,056,000 | 0.71% |
| Sonora Investment Management, LLC | 5,775,000 | $5,568,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,802,000 | $22,095,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 23,405,000 | $22,701,000 | 0.19% |